Fresenius Medical Care AG
FMSHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframePart of the healthcare sector, Fresenius Medical Care AG (FMS) is listed under Medical Care Facilities. With a market capitalization of $12.94B, it sits in large-cap territory. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Market Cap
$12.94B
Beta
0.82
P/E (TTM)
12.95
P/E (Fwd)
6.62
EPS (TTM)
$1.86
EPS (Fwd)
$3.64
ROE
7.8%
ROA
3.6%
Cash
$1.24B
Total Debt
$11.04B
Free CF
$1.67B
52W Change
-10.7%
Annual Financials
Cash vs Debt
Fresenius Medical Care AG carries $11.04B in total debt against $1.24B in cash reserves — debt is roughly 8.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $1.67B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 7.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $17.62B to $19.63B.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing FMS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.